Our passion is to revolutionise the purification industry with cutting edge technology

We established Purius in 2016 to exploit opportunities within the biopharmaceutical sector, specifically delivering a solution to reduce manufacturing costs and increase throughput. To do so, we have established a novel technological process called ‘zero step purification’. The purification stage of pharmaceutical drug production is currently resource-inefficient. Current industry processes involve the use of resin, filters and other consumables, the use of which are no longer required when using our process.

 

We estimate that our platform can eliminate up to 60% of downstream processing costs (DSP). We have identified through extensive market research that DSP is the bottleneck costing an average of 55%-80% of cost of goods (COGs).

Emerging markets such as biosimilars are growing fast but under enormous cost pressure due to the significant costs associated with the current drug refinement processes.

We are keen to disrupt the market with our novel approach that offers significant cost savings and productivity improvements.

OUR WORK

 
 
 

Michael Rose

Co-Founder & CEO

Purification Process Engineer 

Protein Scientist

MEng Biochemical Engineering
Lead Inventor: 3 Patents pending
 

 

Anika Ahmad

Co-Founder

 

Subhas Pradhan

Co-Founder & CTO

Protein Engineer

PhD Biochemical Engineering

BIOLOGICS PURIFICATION SPECIALISTS

Savvas Neophytou 

Co-Founder & Investing Partner

Venture Capitalist

PhD Psychopharmacology

© 2017 Purius Limited